Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until ...

Cardiac Dimensions, a Kirkland, Wash., company with a technology to treat heart valve malfunction, has raised $53 million ...

Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Out-of-hospital mortality before 30 days was 1.2%, with roughly two-thirds of these patients dying from cardiovascular causes ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...

The Duke team performed the world’s first living mitral valve replacement, a type of partial heart transplant, which Duke ...

Growing investments in healthcare infrastructure and advancements in medical research facilities are driving the expansion of ...

The chordae tendineae (CT), often referred to as the “heart strings,” are thin, tendinous structures that connect the heart ...